A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT05364554. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Multicenter, Long-Term Extension, Dose-ranging Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate long-term clinical response of JNJ-77242113 treatment in participants with moderate-to-severe plaque psoriasis.
Study identification
- NCT ID
- NCT05364554
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 227 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 10, 2022 (Actual)
- Primary completion
- Sep 29, 2023 (Actual)
- Completion
- Sep 29, 2023 (Actual)
- Last update posted
- Jun 1, 2026
2022 – 2023
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pacific Skin Institute | Sacramento | California | 95815 | — |
| Renstar Medical Research | Ocala | Florida | 34470 | — |
| Forcare Clinical Research Inc | Tampa | Florida | 33613 | — |
| Arlington Dermatology | Rolling Meadows | Illinois | 60008 | — |
| Indiana Clinical Trial Center | Plainfield | Indiana | 46168 | — |
| Hamzavi Dermatology | Fort Gratiot | Michigan | 48059 | — |
| Vivida Dermatology | Las Vegas | Nevada | 89119 | — |
| Windsor Dermatology, PC | East Windsor | New Jersey | 08520 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| University of Pittsburgh Department of Dermatology | Pittsburgh | Pennsylvania | 15213 | — |
| Modern Research Associates | Dallas | Texas | 75231 | — |
| Center for Clinical Studies | Houston | Texas | 77004 | — |
| Center for Clinical Studies | Webster | Texas | 77598 | — |
| Premier Clinical Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05364554, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 1, 2026 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05364554 live on ClinicalTrials.gov.